Short Courses*


SUNDAY, FEBRUARY 15
AFTERNOON COURSES | 2:00 – 5:00 pm

SC1: Translating CTCs to Clinical Use

Joshua M. Lang, M.D., MS, Assistant Professor of Medicine, Carbone Cancer Center, University of Wisconsin, Wisconsin Institutes for Medical Research

Allison Welsh, Ph.D., CTC Scientist, Foundation Medicine, Inc.

Benjamin Casavant, Ph.D., Vice President, Tasso

SC2: Latest Advances in Molecular Pathology

Iris Schrijver, M.D., Professor of Pathology and Pediatrics; Director, Molecular Pathology Laboratory, Stanford University Medical Center, Lucile Packard Children’s Hospital

Michael H.A. Roehrl, M.D., Ph.D., Director, UHN Program in BioSpecimen Sciences, University of Toronto

SC3: Validation and Compliance Considerations for an NGS Lab

Victoria M. Pratt, Ph.D., FACMG, Director, Pharmacogenomics Laboratory, Medical and Molecular Genetics, Indiana University School of Medicine

Monica J. Basehore, Ph.D., FACMG, Lead Director, Molecular Diagnostic Laboratory; Associate Director, Medical Genetics Training Program, Greenwood Genetic Center

SC4: Sequencing 101

Ryan Kim, Ph.D., Director, UC Davis Genome Center, DNA Technologies and Expression Analysis Cores, University of California, Davis

SC5: PCR Part I: Primer Design for PCR Experiments

Jian Han, Ph.D., Faculty Investigator, iCubate, HudsonAlpha Institute for Biotechnology

Carl T. Wittwer, M.D., Ph.D., Professor, Pathology, University of Utah

SC6: Reimbursement for Advanced Diagnostics: From Clinical Value Establishment to Coverage and Pricing

Catherine Schnabel, Ph.D., Senior Vice President, Research & Development, bioTheranostics, Inc.

Macey Johnson III, Vice President, Managed Care and Reimbursement, bioTheranostics, Inc.

Frieda Gerdes, Managing Director, Management, Gerdes Healthcare Communication UG


DINNER COURSES | 5:30 – 8:30 pm

SC9: Clinical Informatics Needs Co-Organized with of an NGS Lab

Alexis B. Carter, M.D., Assistant Professor, Pathology and Laboratory Medicine; Member, Center for Comprehensive Informatics; Director, Pathology Informatics, Emory University School of Medicine; Chair, AMP Informatics Interest Group; President, Association of Pathology Informatics

Federico A. Monzon, M.D., FCAP, Director, Oncology, InVitae; Adjunct Faculty, Baylor College of Medicine

Mark J. Routbort, M.D., Ph.D., Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center

SC10: Knowing Your NGS Analysis Upstream: Alignments and Variants

Gabe Rudy, Vice President, Product Development, Golden Helix

SC11: Regulatory Compliance in Molecular Diagnostics

Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.

Melina Cimler, Ph.D., Vice President, Head, Global Quality, Illumina, Inc.

SC12: Introduction to Hadoop for Bioinformatics

Martin Gollery, CEO, Tahoe Informatics

SC13: PCR Part II: Digital PCR Applications and Advances

Alison Devonshire, Ph.D., Science Leader, Nucleic Acid Metrology, LGC Genomics

Robert Palais, Ph.D., Associate Professor, Math Dept, Utah Valley University; Research Professor, Pathology Dept, University of Utah


MONDAY, FEBRUARY 16
MORNING COURSES | 8 – 11:00 am

SC17: Commercialization Boot Camp: Manual for Success in Molecular Diagnostics

Harry Glorikian, Healthcare Consultant

Elaine Cheung, Business & Corporate Development, Illumina

SC18: Next-Generation Sequencing as a Diagnostics Platform

Karl Voelkerding, M.D., Associate Professor, Pathology, University of Utah; Medical Director, Advanced Technology and Bioinformatics, ARUP Laboratories

Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory; Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania School of Medicine

SC19: Isolation and Characterization of Cancer Stem Cells

Leslie Crews, Ph.D., Assistant Project Scientist, Catriona Jamieson Laboratory, Sanford Consortium for Regenerative Medicine and MooresUCSD Cancer Center

Kristen M. Smith, Ph.D., Scientist II, Bionomics, Inc.

SC20: Using Preclinical Models in Oncology to Inform First-Man-Trial Design: Tools and Techniques

Arijit Chakravarty, Ph.D., Director, Modeling & Simulation (DMPK), Takeda Pharmaceutical International Co.

SC21: Best Practices in Personalized and Translational Medicine

Erik Bierwagen, Principal Programmer Analyst, Genentech Sergio Rotstein, Ph.D., Director, Research Business Technology, Pfizer, Inc.

Jean Yuan, Senior Programming Analyst, Genentech Doug Garrett, Software Engineer, Genentech

SC22: NGS for Infectious Disease Diagnostics

Speaker to be Announced, Lab of Charles Chiu, M.D., Ph.D., University of California San Francisco



* Separate Registration Require or All Access Registration.



Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

 

2015 MMTC Final Agenda 

Premier Sponsors:

Elsevier 


Jackson Laboratory - small logo 

Leica Biosystems 
 

 NanoString2   

 

Silicon Biosystems 

 

Singulex 

Thomson Reuters-Large 






Local Partners:

BayBio 


biocube 


Cabs 

City of SSF